- Home
- ACHV vs BHR Comparison
ACHV vs BHR Comparison
Compare ACHV & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- BHR
- Stock Information
- Founded
- ACHV N/A
- BHR 2013
- Country
- ACHV United States
- BHR United States
- Employees
- ACHV N/A
- BHR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BHR Real Estate Investment Trusts
- Sector
- ACHV Health Care
- BHR Real Estate
- Exchange
- ACHV Nasdaq
- BHR Nasdaq
- Market Cap
- ACHV 167.6M
- BHR 191.7M
- IPO Year
- ACHV N/A
- BHR N/A
- Fundamental
- Price
- ACHV $4.81
- BHR $2.51
- Analyst Decision
- ACHV Strong Buy
- BHR
- Analyst Count
- ACHV 1
- BHR 0
- Target Price
- ACHV $12.00
- BHR N/A
- AVG Volume (30 Days)
- ACHV 2.4M
- BHR 307.5K
- Earning Date
- ACHV 11-06-2025
- BHR 11-04-2025
- Dividend Yield
- ACHV N/A
- BHR 7.92%
- EPS Growth
- ACHV N/A
- BHR N/A
- EPS
- ACHV N/A
- BHR N/A
- Revenue
- ACHV N/A
- BHR $715,161,000.00
- Revenue This Year
- ACHV N/A
- BHR N/A
- Revenue Next Year
- ACHV N/A
- BHR $0.71
- P/E Ratio
- ACHV N/A
- BHR N/A
- Revenue Growth
- ACHV N/A
- BHR N/A
- 52 Week Low
- ACHV $1.84
- BHR $1.80
- 52 Week High
- ACHV $5.78
- BHR $3.82
- Technical
- Relative Strength Index (RSI)
- ACHV 61.90
- BHR 39.78
- Support Level
- ACHV $4.65
- BHR $2.49
- Resistance Level
- ACHV $5.42
- BHR $2.59
- Average True Range (ATR)
- ACHV 0.44
- BHR 0.10
- MACD
- ACHV 0.02
- BHR -0.02
- Stochastic Oscillator
- ACHV 64.34
- BHR 13.44
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.